| Financial Year |
March 31 2023 |
| Monetary Funds |
328,733,501.89 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
304,940,061.43 |
| Advances to Suppliers |
44,172,424.98 |
| Other Receivables |
24,941,143.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
290,135,557.42 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
418,429.87 |
| Other Current Assets |
5,031,221.60 |
| Total Current Assets |
1,014,220,689.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
10,517,252.22 |
| Long-term Equity Investment |
7,755,885.60 |
| Investment Properties |
112,766,741.90 |
| Fixed Assetes |
115,520,121.87 |
| Under-construction Projects |
5,029,914.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
9,632,871.57 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
165,422,130.25 |
| Deferred Income Tax Assets |
3,961,299.09 |
| Other Non-Current Assets |
7,850,517.48 |
| Sub-Total of Non-Current Assets |
550,343,605.12 |
| Total Assets |
1,564,564,294.55 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
22,029,259.00 |
| Accounts Payable |
402,858,331.87 |
| Accounts Received In Advance |
637,858.92 |
| Employee Compensation Payable |
1,068,725.85 |
| Taxes Payable |
649,105.43 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
14,466,353.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,377,208.00 |
| Other Current Liabilities |
5,506,177.29 |
| Sub-Total of Current Liabilities |
521,490,848.18 |
| Long-term Loans |
-- |
| Bonds Payable |
288,711,639.71 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
300,835,169.72 |
| Total Liabilities |
822,326,017.90 |
| Paid-In Capital(Or Share Stock) |
203,849,297.00 |
| Capital Surplus |
122,000,984.92 |
| Surplus Reserve |
55,544,258.60 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
350,516,489.86 |
| Minority Stockholder's Interest |
-4,980,573.19 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
747,218,849.84 |
| Owner's Equity（Stockholder's Equity） |
742,238,276.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,564,564,294.55 |
